• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Cycling-Lappartient elected unopposed to second term as UCI president

September 24, 2021 by David Barret Leave a Comment

September 24, 2021

(Reuters) – David Lappartient has been re-elected for a four-year second term as president of the International Cycling Union (UCI), the governing body said on Friday, having stood unopposed at its congress during the Road World Championships in Belgium.

Lappartient, who took over from Britain’s Brian Cookson in 2017, will remain in his role until 2025. The Frenchman, 48, was previously president of the European Cycling Union.

In his first term, Lappartient oversaw the introduction of regulations that banned Tramadol, an opiate painkiller, in March 2019 and earlier this year unveiled the six-round UCI Track Champions League aimed scheduled to begin in November.

“Sincere thanks to our National Federations for renewing their confidence in me for another four years. I look forward to working with all stakeholders in my next term as UCI President as we continue to move cycling into the future,” Lappartient wrote on Twitter https://twitter.com/DLappartient/status/1441404016265662464.

In 2016, the UCI agreed to a three-term limit for presidents.

(Reporting by Hritika Sharma in Bengaluru; Editing by Christian Radnedge)

Source Link Cycling-Lappartient elected unopposed to second term as UCI president

David Barret
David Barret

Related posts:

  1. EVGA’s broken RTX 3090 graphics cards were victims of ‘poor workmanship’
  2. Report: NBA won’t mandate vaccine for players
  3. Analysis-China’s hard climate stance with U.S. imperils Glasgow talks
  4. South Korea’s LGES, Hyundai Motor start work on Indonesian EV battery plant

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • AI May Infringe On Your Rights And Insult Your Dignity (Unless We Do Something Soon)
  • How Do You Study Cryptic Species? We’re Finally Lifting The Lid On The World’s Least Understood Mammals
  • Once-In-A-Decade Close Encounter With Hazardous Asteroid 2025 FA22 Approaches
  • With 229 Pairs, This Beautiful Animal Has The Highest Number Of Chromosomes Of Any Animal
  • “An Unimaginable Breakthrough”: Loudest-Ever Gravitational Wave Collision Proves Stephen Hawking Correct
  • Exciting Martian Mudstone Has Features That Might Be Considered Biosignatures
  • How Long Did Dinosaurs Live? “It’s A Big Surprise To People That Work On Them”
  • NASA’s Mysterious Announcement: “Clearest Sign Of Life That We’ve Ever Found On Mars”
  • New Brain Implant Can Decode Your Internal Monologue, Raising Fears Of Mind Reading
  • “Immediate, Sustained, And Devastating” Pain: The Most Venomous Mammal Packs An Extremely Nasty Sting
  • Domestic Cats Keeping Making Hybrids. That’s A Problem, And Yes – That Includes Some Pets
  • These Strange Little Lizards Have Toxic Green Blood, And No One Knows Exactly Why
  • How Does 2-In-1 Shampoo And Conditioner Work?
  • There Are 2-Billion-Year-Old “Millennium Rocks” In A Suburb, Hundreds Of Miles From Their Primeval Home
  • “That’s A Hellfire Missile Smacking Into That UFO”: Strange Video Emerges From US UAP Hearing
  • In 40,000 Years, Voyager 1 Will Have A Close Encounter With Gliese 445
  • Abnormally Long Gamma Ray Burst Unlike Anything We’ve Seen Before Baffles Astronomers
  • Critically Endangered Shark Meat Is Being Sold In US Stores For As Little As $2.99
  • Infectious Mouth Bacteria Lurking In Artery Plaques Could Be Behind Some Heart Attacks
  • What Would You Reach If You Kept Digging Under Antarctica?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version